Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 5
1995 6
1996 9
1997 9
1998 17
1999 14
2000 16
2001 27
2002 22
2003 20
2004 20
2005 16
2006 17
2007 11
2008 9
2009 7
2010 9
2011 17
2012 12
2013 11
2014 12
2015 21
2016 22
2017 18
2018 17
2019 18
2020 17
2021 18
2022 18
2023 13

Text availability

Article attribute

Article type

Publication date

Search Results

405 results

Results by year

Filters applied: . Clear all
Page 1
Lanreotide in metastatic enteropancreatic neuroendocrine tumors.
Caplin ME, Pavel M, Ćwikła JB, Phan AT, Raderer M, Sedláčková E, Cadiot G, Wolin EM, Capdevila J, Wall L, Rindi G, Langley A, Martinez S, Blumberg J, Ruszniewski P; CLARINET Investigators. Caplin ME, et al. Among authors: raderer m. N Engl J Med. 2014 Jul 17;371(3):224-33. doi: 10.1056/NEJMoa1316158. N Engl J Med. 2014. PMID: 25014687 Free article. Clinical Trial.
Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Zucca E, Arcaini L, Buske C, Johnson PW, Ponzoni M, Raderer M, Ricardi U, Salar A, Stamatopoulos K, Thieblemont C, Wotherspoon A, Ladetto M; ESMO Guidelines Committee. Electronic address: Zucca E, et al. Among authors: raderer m. Ann Oncol. 2020 Jan;31(1):17-29. doi: 10.1016/j.annonc.2019.10.010. Epub 2019 Dec 4. Ann Oncol. 2020. PMID: 31912792 Free article. No abstract available.
How I treat medullary thyroid cancer.
Kiesewetter B, Riss P, Scheuba C, Raderer M. Kiesewetter B, et al. Among authors: raderer m. ESMO Open. 2021 Jun;6(3):100183. doi: 10.1016/j.esmoop.2021.100183. Epub 2021 Jun 3. ESMO Open. 2021. PMID: 34091261 Free PMC article. Review.
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study.
Robak T, Jin J, Pylypenko H, Verhoef G, Siritanaratkul N, Drach J, Raderer M, Mayer J, Pereira J, Tumyan G, Okamoto R, Nakahara S, Hu P, Appiani C, Nemat S, Cavalli F; LYM-3002 investigators. Robak T, et al. Among authors: raderer m. Lancet Oncol. 2018 Nov;19(11):1449-1458. doi: 10.1016/S1470-2045(18)30685-5. Epub 2018 Oct 19. Lancet Oncol. 2018. PMID: 30348538 Clinical Trial.
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.
Yao JC, Fazio N, Singh S, Buzzoni R, Carnaghi C, Wolin E, Tomasek J, Raderer M, Lahner H, Voi M, Pacaud LB, Rouyrre N, Sachs C, Valle JW, Fave GD, Van Cutsem E, Tesselaar M, Shimada Y, Oh DY, Strosberg J, Kulke MH, Pavel ME; RAD001 in Advanced Neuroendocrine Tumours, Fourth Trial (RADIANT-4) Study Group. Yao JC, et al. Among authors: raderer m. Lancet. 2016 Mar 5;387(10022):968-977. doi: 10.1016/S0140-6736(15)00817-X. Epub 2015 Dec 17. Lancet. 2016. PMID: 26703889 Free PMC article. Clinical Trial.
Marginal Zone Lymphomas.
Bertoni F, Rossi D, Raderer M, Zucca E. Bertoni F, et al. Among authors: raderer m. Cancer J. 2020 Jul/Aug;26(4):336-347. doi: 10.1097/PPO.0000000000000463. Cancer J. 2020. PMID: 32732678 Review.
How I treat neuroendocrine tumours.
Kiesewetter B, Raderer M. Kiesewetter B, et al. Among authors: raderer m. ESMO Open. 2020 Aug;5(4):e000811. doi: 10.1136/esmoopen-2020-000811. ESMO Open. 2020. PMID: 32817134 Free PMC article. Review.
The multiple faces of marginal zone lymphomas.
Raderer M. Raderer M. Hematol Oncol. 2017 Jun;35 Suppl 1:46-48. doi: 10.1002/hon.2400. Hematol Oncol. 2017. PMID: 28591419 Review. No abstract available.
405 results